1. Controversies in Drug Allergy: Radiographic Contrast Media
Mario Sánchez-Borges, MD, Werner Aberer, MD, Knut Brockow, MD, Gulfem E. Celik, MD, Josefina Cernadas, MD, Paul A. Greenberger, MD, Marie-Soleil Masse, MD, Rik Schrijvers, MD, Axel Trautmann, MD 
The Journal of Allergy and Clinical Immunology: In Practice 
Volume 7, Issue 1, Pages (January 2019)
DOI: /j.jaip
Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Figure 1
Mechanisms of hypersensitivity reactions to radiocontrast media. RCM, Radiocontrast media.
The Journal of Allergy and Clinical Immunology: In Practice 2019 7, 61-65DOI: ( /j.jaip )
Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3. Figure 2
Skin test–based management of patients with immediate reactions to radiocontrast media. DPT, Drug provocation test; RCM, radiocontrast media.
The Journal of Allergy and Clinical Immunology: In Practice 2019 7, 61-65DOI: ( /j.jaip )
Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4. Figure 3
Skin test–based management of patients with nonimmediate reactions to radiocontrast media (RCM). RCM are contraindicated in patients with Stevens-Johnson syndrome, toxic epidermal necrolysis, or DRESS. DRESS, Drug reaction with eosinophilia and systemic symptoms.
The Journal of Allergy and Clinical Immunology: In Practice 2019 7, 61-65DOI: ( /j.jaip )
Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions